Weisan Pan

10.5k total citations
256 papers, 8.6k citations indexed

About

Weisan Pan is a scholar working on Pharmaceutical Science, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Weisan Pan has authored 256 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Pharmaceutical Science, 63 papers in Biomaterials and 62 papers in Biomedical Engineering. Recurrent topics in Weisan Pan's work include Advanced Drug Delivery Systems (96 papers), Drug Solubulity and Delivery Systems (72 papers) and Nanoparticle-Based Drug Delivery (47 papers). Weisan Pan is often cited by papers focused on Advanced Drug Delivery Systems (96 papers), Drug Solubulity and Delivery Systems (72 papers) and Nanoparticle-Based Drug Delivery (47 papers). Weisan Pan collaborates with scholars based in China, United Kingdom and United States. Weisan Pan's co-authors include Xinggang Yang, Shufang Nie, Hao Pan, Shihui Yu, Guoxin Tan, Kai Chen, Ning Li, Mengsuo Cui, Mi Wang and Jinyu Li and has published in prestigious journals such as Biomaterials, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Weisan Pan

252 papers receiving 8.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weisan Pan China 51 4.1k 2.3k 2.0k 2.0k 1.0k 256 8.6k
Jaleh Varshosaz Iran 52 3.6k 0.9× 3.6k 1.5× 2.4k 1.2× 2.1k 1.1× 304 0.3× 395 10.9k
Pradeep Kumar South Africa 48 2.0k 0.5× 3.1k 1.3× 1.8k 0.9× 2.7k 1.4× 261 0.3× 420 10.2k
Praneet Opanasopit Thailand 47 2.8k 0.7× 2.9k 1.3× 2.0k 1.0× 1.3k 0.7× 279 0.3× 346 7.6k
F. Siepmann France 41 3.8k 0.9× 2.1k 0.9× 931 0.5× 1.4k 0.7× 205 0.2× 151 7.4k
M. N. V. Ravi Kumar United States 45 3.1k 0.7× 4.4k 1.9× 2.4k 1.2× 1.7k 0.9× 321 0.3× 114 10.7k
Maria Cristina Bonferoni Italy 53 3.6k 0.9× 2.3k 1.0× 1.2k 0.6× 895 0.5× 685 0.7× 218 8.1k
Dennis Douroumis United Kingdom 49 3.2k 0.8× 917 0.4× 1.1k 0.5× 2.1k 1.1× 240 0.2× 156 6.9k
Dimitrios G. Fatouros Greece 41 1.7k 0.4× 1.3k 0.5× 1.0k 0.5× 1.7k 0.9× 186 0.2× 179 5.1k
Michael A. Repka United States 47 3.9k 1.0× 854 0.4× 1.5k 0.7× 1.6k 0.8× 176 0.2× 178 7.2k
Xinggang Yang China 34 1.7k 0.4× 1.1k 0.5× 899 0.4× 856 0.4× 394 0.4× 122 3.7k

Countries citing papers authored by Weisan Pan

Since Specialization
Citations

This map shows the geographic impact of Weisan Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weisan Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weisan Pan more than expected).

Fields of papers citing papers by Weisan Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weisan Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weisan Pan. The network helps show where Weisan Pan may publish in the future.

Co-authorship network of co-authors of Weisan Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Weisan Pan. A scholar is included among the top collaborators of Weisan Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weisan Pan. Weisan Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gong, Ye, et al.. (2025). M1 macrophage membrane-coated nickel-arsenic nanocomplex promoting synergistic treatment of hepatocellular carcinoma. Journal of Pharmaceutical Sciences. 114(2). 1280–1295.
2.
Pan, Hao, et al.. (2024). Eudragit S100 coated nanodiamond-based nanoparticles as an oral chemo-photothermal delivery system for local treatment of colon cancer. Colloids and Surfaces B Biointerfaces. 237. 113849–113849. 9 indexed citations
3.
4.
Pan, Weisan, et al.. (2022). Microvesicles as drug delivery systems: A new frontier for bionic therapeutics in cancer. Journal of Drug Delivery Science and Technology. 79. 104088–104088. 10 indexed citations
5.
6.
Zhang, Wenji, Xuedong Li, Tiantian Ye, et al.. (2013). Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology. International Journal of Pharmaceutics. 454(1). 354–366. 76 indexed citations
7.
Han, Cuiyan, Yao Li, Chang Liu, et al.. (2013). Small peptide-modified nanostructured lipid carriers distribution and targeting to EGFR-overexpressing tumorin vivo. Artificial Cells Nanomedicine and Biotechnology. 42(3). 161–166. 21 indexed citations
8.
Pan, Weisan. (2011). In vitro study on baicalin pH-triggered ophthalmic in situ gel system. Zhongguo xin yao zazhi. 1 indexed citations
9.
Pan, Weisan, et al.. (2011). In vitro and in vivo evaluation of folate receptor-targeting amphiphilic copolymer-modified liposomes loaded with docetaxel. International Journal of Nanomedicine. 6. 1167–1167. 54 indexed citations
10.
Zhang, Huihui, et al.. (2011). Novel ophthalmic timolol meleate liposomal-hydrogel and its improved local glaucomatous therapeutic effectin vivo. Drug Delivery. 18(7). 502–510. 21 indexed citations
11.
Pan, Weisan. (2010). Preparation of dipyridamole microemulsion and its quality evaluation. Zhongguo xin yao zazhi. 1 indexed citations
12.
Pan, Weisan. (2009). Preparation and in vitro evaluation of thermo-and ion-sensitive in situ gels of vibavirin via intranasal administration. Shenyang Yaoke Daxue xuebao. 1 indexed citations
13.
Yin, Fei, Wei Li, & Weisan Pan. (2009). Preparation and drug release in vitro of the metformin hydrochloride osmotic pump controlled release tablets. 12(3). 194–196. 1 indexed citations
14.
Pan, Weisan. (2008). Preparation of gliclazide push-pull osmotic pump system. Zhongguo xin yao zazhi. 1 indexed citations
15.
Pan, Weisan. (2008). Pharmacokinetics of drug resin complexes osmotic pump tablet loaded propranolol in Beagle dogs. Chinese Journal of New Drugs and Clinical Remedies. 1 indexed citations
16.
Pan, Weisan. (2008). Determination of sarsasapogenin in Rhizoma Anemarrhenae with precolumn derivatization by HPLC. Shenyang Yaoke Daxue xuebao. 1 indexed citations
17.
Zhang, Xinxin, Weisan Pan, Li Gan, Chunliu Zhu, & Yong Gan. (2008). Effects of breast cancer resistance protein inhibitors and pharmaceutical excipients on decreasing gastrointestinal toxicity of camptothecin analogs. Acta Pharmacologica Sinica. 29(11). 1391–1398. 14 indexed citations
18.
Pan, Weisan. (2007). Study on Inclusive Reaction of Water-Soluble β-Cyclodextrin Polymer with Glipizide. Zhōnghuá yàoxué zázhì. 2 indexed citations
19.
Li, Ying, et al.. (2006). Studies on Preparation of Puerarin Phytosomes and Their Solid Dispersions. Zhōnghuá yàoxué zázhì. 13 indexed citations
20.
Liu, Hui, et al.. (2003). Potential utility of various protease inhibitors for improving the intestinal absorption of insulin in rats. Journal of Pharmacy and Pharmacology. 55(11). 1523–1529. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026